U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
130591130591Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy VolunteersCompletedHas ResultsSafety and Tolerability of EGT0001474 in Healthy VolunteersDrug: EGT0001474|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00854113
130592130592Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: Antidepressant + placebo|Drug: Antidepressant + cariprazine (0.1-0.3 mg/day)|Drug: Antidepressant + cariprazine (1-2 mg/d)https://ClinicalTrials.gov/show/NCT00854100
130593130593Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic FibrosisCompletedHas ResultsChronic Hepatitis C InfectionDrug: Fuzheng Huayu|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00854087
130594130594Neurostimulation for the Treatment of Post-Operative IleusWithdrawnNo Results AvailableIleusDevice: ElectroCore RMS-1100 Resolution Motility Systemâ„¢https://ClinicalTrials.gov/show/NCT00854074
130595130595Study of T-PRED(TM) Compared to Pred Forte(R) IICompletedNo Results AvailableCataractDrug: T-Pred|Drug: Pred Fortehttps://ClinicalTrials.gov/show/NCT00854061
130596130596The Performance of Pulse Oximeters in Pediatric Patients With Low Oxygen Saturation LevelsCompletedNo Results AvailablePediatric Patients Receiving Cardiopulmonary by-Pass.https://ClinicalTrials.gov/show/NCT00854048
130597130597MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes MellitusDrug: MK-0431/ONO-5435|Drug: MK-0431/ONO-5435https://ClinicalTrials.gov/show/NCT00854035
130598130598Genetic Susceptibility to Kidney CancerRecruitingNo Results AvailableRenal Cell Carcinomahttps://ClinicalTrials.gov/show/NCT00854022
130599130599Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male SubjectsTerminatedNo Results AvailableHealthyDrug: BLI-489|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00854009
130600130600Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast CancerCompletedNo Results AvailableBreast CancerDrug: acolbifene hydrochloride|Other: questionnaire administration|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00853996
130601130601Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: [14C] AZD0530https://ClinicalTrials.gov/show/NCT00853983
130602130602Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract SurgeryCompletedHas ResultsPain|InflammationDrug: Bromfenac Ophthalmic Solution|Drug: Placebo Comparatorhttps://ClinicalTrials.gov/show/NCT00853970
130603130603Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 HypertensionCompletedHas ResultsHypertensionDrug: Aliskiren/Amlodipine|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT00853957
130604130604Effect of Sitagliptin on Graft Function Following Islet TransplantationRecruitingNo Results AvailableIslet TransplantationDrug: sitagliptinhttps://ClinicalTrials.gov/show/NCT00853944
130605130605Biomarker - Panitumumab Response With KRAS Wild Type MCCActive, not recruitingNo Results AvailableMetastatic Colorectal CancerDrug: Panitumumabhttps://ClinicalTrials.gov/show/NCT00853931
130606130606Clinical Practice Intensity: Comparing Veterans Affairs (VA) to Private Sector PhysiciansActive, not recruitingNo Results AvailablePhysician Survey Response RatesOther: $20 cash|Other: $50 cash|Other: $50 check|Other: $100 checkhttps://ClinicalTrials.gov/show/NCT00853918
130607130607Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?CompletedNo Results AvailableGlaucomaDrug: Triesence|Drug: balanced salt solution BSShttps://ClinicalTrials.gov/show/NCT00853905
130608130608Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg TabletsCompletedNo Results AvailableHealthyDrug: Controlled-Release Oxycodone Hydrochloride 40 mg tablet|Drug: OxyContin® 40 mg tablethttps://ClinicalTrials.gov/show/NCT00853892
130609130609An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's DiseaseTerminatedNo Results AvailableParkinson's DiseaseDietary Supplement: Folic Acid, Vitamin B6, Vitamin B12|Dietary Supplement: B6, B12, L-methylfolate|Dietary Supplement: B6, B12, Placebohttps://ClinicalTrials.gov/show/NCT00853879
130610130610Enhancement of Motor Function With Reboxetine and Transcranial Direct Current StimulationRecruitingNo Results AvailableCerebral StrokeDrug: reboxetine|Drug: Placebo|Device: tDCS verum|Device: tDCS shamhttps://ClinicalTrials.gov/show/NCT00853866
130611130611EnSeal Device Versus Ferguson Technique in HemorrhoidectomyActive, not recruitingNo Results AvailableHemorrhoidsDevice: EnSeal Device|Procedure: Ferguson Hemorrhoidectomy techniquehttps://ClinicalTrials.gov/show/NCT00853853
130612130612Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving MaravirocCompletedHas ResultsAIDSDrug: Maraviroc|Drug: Vardenafil|Drug: Maraviroc|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00853840
130613130613Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease PatientsCompletedHas ResultsCoronary Artery Disease (CAD)|Coronary AtherosclerosisDrug: Placebo|Drug: Aliskirenhttps://ClinicalTrials.gov/show/NCT00853827
130614130614Increasing Youth Physical Activity: Neighborhood Environment InfluencesRecruitingNo Results AvailableObesity|OverweightBehavioral: Access to sedentary behaviorshttps://ClinicalTrials.gov/show/NCT00853814
130615130615Integrating Lifestyle Therapy for Diabetes Prevention Into Primary CareCompletedNo Results AvailablePre-Diabetes|Metabolic Syndrome|Type 2 DiabetesBehavioral: Lifestyle intervention and provider feedbackhttps://ClinicalTrials.gov/show/NCT00853801
130616130616Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate MofetilCompletedNo Results AvailableSystemic Sclerosishttps://ClinicalTrials.gov/show/NCT00853788
130617130617Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic GroupsCompletedNo Results AvailableHealthy|Heart DiseaseOther: No intervention, observational studyhttps://ClinicalTrials.gov/show/NCT00853775
130618130618Atacicept in Multiple Sclerosis Extension Study, Phase IITerminatedNo Results AvailableRelapsing Multiple SclerosisDrug: Atacicept|Drug: Atacicepthttps://ClinicalTrials.gov/show/NCT00853762
130619130619Immune Response In Children Revaccinated With Pneumococcal Conjugate VaccineCompletedHas ResultsInvasive Pneumococcal DiseaseBiological: 13-valent pneumococcal conjugate vaccine (13vPnC)|Procedure: Blood drawhttps://ClinicalTrials.gov/show/NCT00853749
130620130620Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodoneâ„¢ 30 mg TabletsCompletedNo Results AvailableHealthyDrug: Roxicodoneâ„¢ tablet 30 mg|Drug: Oxycodone hydrochloride tablet 30 mghttps://ClinicalTrials.gov/show/NCT00853736

* Görseller ve İçerik tekif hakkına sahip olabilir